Petros Pharmaceuticals Inc (PTPI): Rasio rega marang dodolan

Logo korporat perusahaan Petros (PTPI)

The normalized P/S ratio of Petros Pharmaceuticals (PTPI) reflects the market valuation of Petros Pharmaceuticals, where the 0.20 mark characterizes this parameter. This trend is driven by the availability of over-the-counter drugs and the cost of components. Stability is maintained through the full localization of US logistics. Simultaneously, the business is implementing eco-friendly packaging and reducing its carbon footprint, ensuring high occupational safety standards.

PTPI Kapitalisasi marang pendapatan Petros Pharma (04.07.2022 - 28.06.2025)

Rincian metrik lan analitis perusahaan Petros Pharmaceuticals Inc (PTPI)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega Petros Pharmaceuticals Inc|PTPI - Bagan rega target
- data kapitalisasi bursa:
Biji pasar Petros Pharma|PTPI - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Aset Bersih saben Saham Petros Pharmaceuticals|PTPI - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku petrospharma.com|PTPI - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Petros Pharmaceuticals|PTPI - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal petrospharma.com|PTPI - Utang perusahaan|Utang-utang marang aset resik Petros Pharmaceuticals, Inc.|PTPI - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Petros Pharmaceuticals|Rasio likuiditas kritis petrospharma.com
- data bathi lan kelipatan valuasi:
PTPI - Bathi resik|Penghasilan resik sing dikarepake Petros Pharmaceuticals|PTPI - Pangali P/E|Pangali Forward P/E Petros Pharma|PTPI - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Petros Pharmaceuticals|PTPI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Petros Pharmaceuticals|PTPI - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan petrospharma.com|PTPI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Petros Pharmaceuticals
- indikator pendapatan dodolan lan penghasilan bisnis:
PTPI - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan Petros|PTPI - Kapitalisasi marang pendapatan|Multiplikator Forward P/S Petros Pharmaceuticals, Inc.
Analisis fundamental perusahaan:PTPI, Petros
Produk dadi Petros Pharmaceuticals, Inc.

Steady demand for urological drugs and insurance coverage of revenues for Petros Pharmaceuticals (PTPI) minimize the impact of market cyclicality on the business. The ratio of market capitalization to annual revenue determines the value of a single dollar of sales, helping investors find the balance between asset undervaluation and stagnation, which is clearly reflected in the P/S multiple time chart.

Karo sapa Petros Pharmaceuticals saingan

HLN (Haleon) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue Inc KVUE|Verona Pharma Corp - Rasio rega marang pendapatan|MENS: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Rasio rega marang pendapatan|Perrigo Company PLC - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan alvotech.com|Multiplikator P/S Liquidia Technologies|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|ANIP: Rasio rega marang dodolan|Multiplikator P/S MNKD (MannKind Corp)|Koefisien rega marang pendapatan Amphastar (AMPH)|PCRX: Kapitalisasi marang pendapatan|SPRY - Multiplikator P/S|Theravance Biopharma, Inc. (TBPH) - Rasio rega marang pendapatan|AQST (Aquestive Therapeutics) - Rasio rega marang pendapatan|SCPH (scpharmaceuticals.com) - Multiplikator P/S|TECX: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S EPRX (Eupraxia Pharmaceuticals)|Rasio kapitalisasi pasar marang pendapatan BHST|Invizyne Technologies - Multiplikator P/S|oramed.com (ORMP) - Kapitalisasi marang pendapatan|ENTX (enterabio.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan HYFT|ABVC (ABVC BioPharma, Inc) - Multiplikator P/S|Multiplikator P/S cumberlandpharma.com|Rasio rega marang pendapatan Quantum BioPharma (QNTM)|FibroGen (FGEN) - Multiplikator rega marang pendapatan|Multiplikator P/S TELO (telomirpharma.com)|RANI - Kapitalisasi marang pendapatan|SNYR - Rasio rega marang pendapatan|rallybio.com - Kapitalisasi marang volume dodolan|LEXX: Multiplikator P/S|Kapitalisasi marang pendapatan Pulmatrix Inc|PTHL (Pheton Holdings) - Multiplikator P/S|Rega marang dodolan Aptorum Group Limited APM|Rasio rega marang pendapatan Lyra Therapeutics (LYRA)|Kapitalisasi marang pendapatan Impact BioMedical Inc IBO|Rasio rega marang pendapatan tnfpharma.com TNFA|Rasio kapitalisasi pasar marang pendapatan YCBD|PainReform Ltd - Multiplikator P/S|Altamira Therapeutics Ltd (CYTO) - Kapitalisasi marang pendapatan|lipella.com (LIPO) - Rasio rega marang pendapatan|OptiNose (OPTN) - Multiplikator P/S|PIRS (Pieris Pharmaceuticals Inc) - Multiplikator P/S|PROC: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S QLI|SLRN - Rega marang dodolan|Multiplikator P/S TFFP (TFF Pharmaceuticals, Inc)